Amedeo Smart

Free Medical Literature Service

 

Amedeo

Colorectal Neoplasms
  Free Subscription

Articles published in
J Surg Oncol
    July 2024
  1. YAO X, Zhou Z, Mao S, Cao J, et al
    Lymph node metastasis detection using artificial intelligence in T1 colorectal cancer: A comprehensive systematic review.
    J Surg Oncol. 2024 Jul 17. doi: 10.1002/jso.27766.
    >> Share

  2. XIA L, Yin R, Mao L, Shi X, et al
    Prevalence and impact of frailty in patients undergoing colorectal cancer surgery: A systematic review and meta-analysis based on modified frailty index.
    J Surg Oncol. 2024 Jul 17. doi: 10.1002/jso.27778.
    >> Share

  3. TINSLEY N, O'Dwyer ST, Nagaraju R, Chakrabarty B, et al
    Preoperative chemotherapy response and survival in patients with colorectal cancer peritoneal metastases.
    J Surg Oncol. 2024 Jul 16. doi: 10.1002/jso.27776.
    >> Share

  4. SCHABL L, Connelly TM, de Camargo MGM, Sancheti H, et al
    Crohn's disease-related versus sporadic colorectal cancer: A stage-matched case-control study based on four decades of experience.
    J Surg Oncol. 2024 Jul 14. doi: 10.1002/jso.27768.
    >> Share

  5. VAZ DA SILVA DG, de Ribeiro HSC, Dos Santos GO, Lindote MVN, et al
    Dense tumor-infiltrating lymphocytes (TILs) in liver metastasis from colorectal cancer are related to improved overall survival.
    J Surg Oncol. 2024 Jul 1. doi: 10.1002/jso.27759.
    >> Share

  6. RAY-OFFOR E, Nagarajan A, Horesh N, Emile SH, et al
    Effect of neoadjuvant therapy regimens on lymph nodes yield in rectal cancer.
    J Surg Oncol. 2024;130:125-132.
    >> Share

  7. CAI M, Blythe N, Jo A, Wong SL, et al
    Electronic health record-integrated questionnaires in colorectal surgery patients as a new standard: Could preoperative bowel function be used to predict postoperative patient-reported outcomes?
    J Surg Oncol. 2024;130:133-139.
    >> Share

  8. DAVIS JMK, Niazi MKK, Ricker AB, Tavolara TE, et al
    Predicting response to neoadjuvant chemotherapy for colorectal liver metastasis using deep learning on prechemotherapy cross-sectional imaging.
    J Surg Oncol. 2024;130:93-101.
    >> Share

    June 2024
  9. SUGIYAMA M, Nishijima TF, Kasagi Y, Uehara H, et al
    Impact of comprehensive geriatric assessment on treatment strategies and complications in older adults with colorectal cancer considering surgery.
    J Surg Oncol. 2024 Jun 16. doi: 10.1002/jso.27736.
    >> Share

  10. HERNANDEZ MC, Fan D, Sandhu J, Mahuron K, et al
    Recurrence patterns after complex multimodality therapy and hepatic arterial infusion for colorectal liver metastases: A reflection of biology and technique.
    J Surg Oncol. 2024;129:1254-1264.
    >> Share

  11. SURAJU MO, Freischlag K, McKeen A, Nayyar A, et al
    Evaluation of association between center colorectal neuroendocrine neoplasm volume and survival among patients with colorectal neuroendocrine carcinoma.
    J Surg Oncol. 2024;129:1449-1455.
    >> Share

  12. CAI M, Cotter RR, Wong SL, Mayo SW, et al
    Evaluating clinical practice guidelines for the management of rectal cancer: Did they get it RIGHT?
    J Surg Oncol. 2024;129:1475-1480.
    >> Share

    May 2024
  13. BENDARI A, Hammoud H, Kumar SK, Harshan M, et al
    Commentary on Tumor deposits are associated with a higher risk of peritoneal disease in non-metastatic colorectal cancer patients.
    J Surg Oncol. 2024 May 22. doi: 10.1002/jso.27669.
    >> Share

  14. BREWER J, Kamara M, Huebner M, Taxakis E, et al
    Operative trends following the adoption of nonoperative management of rectal cancer.
    J Surg Oncol. 2024;129:1139-1149.
    >> Share

  15. LABADIE KP, Olson KA, Sun SH, Ituarte PHG, et al
    Outcomes of rectal cancer patients who refuse surgery after incomplete clinical response to neoadjuvant therapy.
    J Surg Oncol. 2024;129:1131-1138.
    >> Share

  16. KAZI M, Choubey K, Patil P, Jaiswal D, et al
    Patient reported outcomes after multivisceral resection for advanced rectal cancers in female patients.
    J Surg Oncol. 2024;129:1106-1112.
    >> Share

  17. NAKAO E, Honda M, Uesugi N, Osakabe M, et al
    Evaluation of the prognostic impact of pathologic tumor regression grade on patients with colorectal cancer after preoperative chemoradiotherapy.
    J Surg Oncol. 2024 May 1. doi: 10.1002/jso.27662.
    >> Share

    April 2024
  18. GONCALVES AFK, de Barros ABD, Castro LM, Dutra JB, et al
    Accuracy of surgeons for predicting radiological sarcopenia in colorectal cancer surgery.
    J Surg Oncol. 2024 Apr 18. doi: 10.1002/jso.27652.
    >> Share

  19. BEPPU T, Yamamura K, Imai K, Hayashi H, et al
    Recurrence-risk stratification using the Beppu score and selection of perioperative chemotherapy for colorectal liver metastases.
    J Surg Oncol. 2024;129:893-900.
    >> Share

  20. STEVANATO FILHO PR, Bezerra TS, Marques TMDM, Nahime RH, et al
    A precise approach to robotic intracorporeal rectal transection and hand-sewn purse-string anastomosis for low anterior resection.
    J Surg Oncol. 2024;129:939-944.
    >> Share

  21. WEHRLE CJ, Woo K, Chang J, Gamaleldin M, et al
    Impact of neoadjuvant therapy on nodal harvest in clinical stage III rectal cancer: Establishing optimum cut-offs by disease response.
    J Surg Oncol. 2024;129:945-952.
    >> Share

  22. ALI D, Syed M, Gamboa AC, Hawkins AT, et al
    Association of omental pedicled flap with anastomotic leak following low anterior resection for rectal cancer.
    J Surg Oncol. 2024;129:930-938.
    >> Share

    March 2024
  23. EMILE SH, Horesh N, Garoufalia Z, Gefen R, et al
    A national database analysis of the evolution of outcomes of surgery for anal melanoma.
    J Surg Oncol. 2024 Mar 27. doi: 10.1002/jso.27631.
    >> Share

  24. GKEKAS I, Jan N, Kaprio T, Beilmann-Lehtonen I, et al
    Sporadic deficient mismatch repair in colorectal cancer increases the risk for non-colorectal malignancy: A European multicenter cohort study.
    J Surg Oncol. 2024 Mar 12. doi: 10.1002/jso.27619.
    >> Share

  25. XU F, Yang XY, Hu Q
    Prediction of symptomatic anastomotic leak after rectal cancer surgery.
    J Surg Oncol. 2024;129:665-667.
    >> Share

  26. AKTURK ESEN S, Uncu D
    Is the watch-and-wait strategy suitable for every patient who has achieved a complete clinical response with neoadjuvant treatment in locally advanced rectum cancer?
    J Surg Oncol. 2024;129:459-460.
    >> Share

  27. LO WM, Dogeas E, Etherington MS, Ferrone C, et al
    Long-term overall survival in patients undergoing liver resection for metastatic anal squamous cell carcinoma.
    J Surg Oncol. 2024;129:568-573.
    >> Share

  28. SHEHATA MS, Lofftus SY, Park JY, Singh AS, et al
    Sarcoma in patients with Lynch syndrome and response to immunotherapy.
    J Surg Oncol. 2024;129:820-826.
    >> Share

  29. FILHO PRS, Bezerra TS, Marques TMDM, Nahime RH, et al
    An alternative robotic approach to precise colorectal transection and single-staple anastomosis in high anterior resection: Video correspondence.
    J Surg Oncol. 2024;129:802-803.
    >> Share

  30. SHEN Y, Yang T, Huang L, Wang Z, et al
    Response to prediction of symptomatic anastomotic leak after rectal cancer surgery.
    J Surg Oncol. 2024;129:835-836.
    >> Share

    February 2024
  31. LAHNAOUI O, Essangri H, El Bahaoui N, Majbar MA, et al
    From burden to relief: The economic and quality-of-life advantages of pseudo continent perineal colostomy in ultra-low rectal cancer patients.
    J Surg Oncol. 2024;129:297-307.
    >> Share

  32. XIAO J, Zhang X, Gu C, Yang X, et al
    Comparison of laparoscopic lateral lymph node dissection for rectal cancer with and without routine resection of the visceral branches of internal iliac artery.
    J Surg Oncol. 2024;129:308-316.
    >> Share

  33. ANNICCHIARICO A, Montali F, Baldinu M, Casali L, et al
    Leiomyosarcoma of the rectum: A systematic review of recent literature.
    J Surg Oncol. 2024;129:365-380.
    >> Share

  34. GUPTA A, Garabetian C, Cologne K, Duldulao MP, et al
    Complete mesocolic excision and extended lymphadenectomy: Where should we stand?
    J Surg Oncol. 2024;129:338-348.
    >> Share

  35. LI C, Luan J, Ji X, Wang X, et al
    The influence of neoadjuvant chemoradiotherapy combined with lateral lymph nodes dissection or not on the local recurrence of low to intermediate-stage II/III rectal cancer.
    J Surg Oncol. 2024;129:273-283.
    >> Share

  36. SHEN Y, Huang LB, Lu A, Yang T, et al
    Prediction of symptomatic anastomotic leak after rectal cancer surgery: A machine learning approach.
    J Surg Oncol. 2024;129:264-272.
    >> Share

  37. BAUER PS, Gamboa AC, Otegbeye EE, Chapman WC, et al
    Short-course radiation with consolidation chemotherapy does not increase operative morbidity compared to long-course chemoradiation: A retrospective study of the US rectal cancer consortium.
    J Surg Oncol. 2024;129:254-263.
    >> Share

    January 2024
  38. ALTOMARE NJ, Mulcahy MF
    Evolution of therapy for locally advanced rectal cancer.
    J Surg Oncol. 2024;129:78-84.
    >> Share

    December 2023
  39. WEHRLE CJ, Perlmutter B, Hong H, Chang J, et al
    Impact of autotransfusion on recurrence of colorectal cancer liver metastasis: Long-term follow-up of patients undergoing curative intent hepatectomy.
    J Surg Oncol. 2023 Dec 27. doi: 10.1002/jso.27569.
    >> Share

  40. OKAMOTO K, Sasaki K, Nozawa H, Murono K, et al
    Poor prognosis of young male patients with stage III colorectal cancer: A multicenter retrospective study.
    J Surg Oncol. 2023 Dec 19. doi: 10.1002/jso.27557.
    >> Share

  41. KIM SJ, Lee YJ, Park MY, Yang SY, et al
    Postchemoradiation magnetic resonance imaging circumferential resection margin predicts treatment failure after multidisciplinary directed sphincter preservation in low rectal cancer.
    J Surg Oncol. 2023;128:1365-1371.
    >> Share

  42. SHAKER N, Shaker N, Abid A, Shah S, et al
    Muir-Torre syndrome and recent updates on screening guidelines: The link between colorectal tumors and sebaceous adenomas in unusual locations.
    J Surg Oncol. 2023;128:1380-1384.
    >> Share

    November 2023
  43. COS H, Shen P
    Comparison of outcomes between surgical treatment of colorectal cancer metastatic to the liver and the peritoneum: Review of the literature.
    J Surg Oncol. 2023 Nov 22. doi: 10.1002/jso.27524.
    >> Share

  44. HAN Z, Tong Y, Zhu X, Sun D, et al
    Development and external validation of MRI-based RAS mutation status prediction model for liver metastases of colorectal cancer.
    J Surg Oncol. 2023 Nov 16. doi: 10.1002/jso.27508.
    >> Share

  45. DARE AJ, Olatoke SA, Okereke CE, Abdulkareem FB, et al
    The African Research Group for Oncology: A decade fostering colorectal cancer research in Nigeria.
    J Surg Oncol. 2023;128:1011-1020.
    >> Share

  46. SEDIGHIM S, Khan A, Li AY, Tajik F, et al
    Adoption of cytoreductive surgery in the management of peritoneal malignancies-Global trends.
    J Surg Oncol. 2023;128:1021-1031.
    >> Share

    October 2023
  47. DEBOEVER N, Bayley EM, Eisenberg MA, Hofstetter WL, et al
    Do resected colorectal cancer patients need early chest imaging? Impact of clinicopathologic characteristics on time to development of pulmonary metastases.
    J Surg Oncol. 2023 Oct 24. doi: 10.1002/jso.27490.
    >> Share

  48. NAKAMURA Y, Kawase M, Kawabata Y, Kanto S, et al
    Impact of malnutrition on cancer recurrence, colorectal cancer-specific death, and non-colorectal cancer-related death in patients with colorectal cancer who underwent curative surgery.
    J Surg Oncol. 2023 Oct 16. doi: 10.1002/jso.27488.
    >> Share

  49. WONG P, Victorino GP, Miraflor E, Alseidi A, et al
    Impact of safety-net hospital burden on achievement of textbook oncologic outcomes following resection in for stage I-IV colorectal cancer.
    J Surg Oncol. 2023 Oct 10. doi: 10.1002/jso.27474.
    >> Share

  50. SHEN Y, Yang TH, Deng X, Wu Q, et al
    Closure of pelvic peritoneum with bladder peritoneum flap reconstruction after laparoscopic extralevator abdominoperineal excision: A prospective stage II study.
    J Surg Oncol. 2023;128:851-859.
    >> Share

  51. GHABRA S, Chang D, Sugarbaker PH
    Prognostic indicators for colorectal peritoneal metastases are different for patients with complete versus incomplete cytoreductive surgery.
    J Surg Oncol. 2023;128:860-868.
    >> Share

    September 2023
  52. NUMATA K, Numata M, Shirai J, Sawazaki S, et al
    Short- and long-term outcomes of transanal decompression tube and self-expandable metallic stent for obstructive colorectal cancer based on a multicenter database (KYCC2110).
    J Surg Oncol. 2023 Sep 27. doi: 10.1002/jso.27454.
    >> Share

  53. ENDO Y, Rueda BO, Woldesenbet S, Munir MM, et al
    The impact of recurrence timing and tumor burden score on overall survival among patients undergoing repeat hepatectomy for colorectal liver metastases.
    J Surg Oncol. 2023;128:560-568.
    >> Share

  54. YANG XY, Hu Q
    Computed tomography-based preoperative muscle measurements as prognostic factors for anastomotic leakage following oncological sigmoid and rectal resections.
    J Surg Oncol. 2023;128:701-703.
    >> Share

  55. EMILE SH, Horesh N, Garoufalia Z, Gefen R, et al
    Propensity-score matched analysis of the pathologic outcomes and survival benefits of neoadjuvant therapy in stage II-III anal adenocarcinoma.
    J Surg Oncol. 2023;128:585-594.
    >> Share

    August 2023
  56. KOZMAN MA, Fisher OM, Liauw W, Morris DL, et al
    External validation of prognostic scores and comparison of predictive accuracy for patients with colorectal cancer with peritoneal metastases considered for cytoreductive surgery and intraperitoneal chemotherapy.
    J Surg Oncol. 2023 Aug 21. doi: 10.1002/jso.27416.
    >> Share

  57. LIN WL, Wu LM, Huang WT, Guo HR, et al
    Age as a modifier of the effects of sarcopenia on survival among colon cancer patients after surgery.
    J Surg Oncol. 2023 Aug 17. doi: 10.1002/jso.27405.
    >> Share

  58. XIAO J, Shen Y, Yang X, Zeng H, et al
    The same parastomal hernia repairs rate in the different approaches to colostomy.
    J Surg Oncol. 2023;128:304-312.
    >> Share

    July 2023
  59. COHEN R, Platell CF
    Metachronous colorectal cancer metastasis: Who, what, when and what to do about it.
    J Surg Oncol. 2023 Jul 17. doi: 10.1002/jso.27400.
    >> Share

  60. RADOMSKI SN, Chen SY, Stem M, Done JZ, et al
    Simultaneous resection of colorectal cancer and synchronous colorectal liver metastases: A risk stratified analysis of the NSQIP database.
    J Surg Oncol. 2023 Jul 13. doi: 10.1002/jso.27393.
    >> Share

  61. FASTNER S, Hieken TJ, McWilliams RR, Hyngstrom J, et al
    Anorectal melanoma.
    J Surg Oncol. 2023 Jul 3. doi: 10.1002/jso.27381.
    >> Share

  62. BEDRIKOVETSKI S, Traeger L, Sammour T
    Reply to Letter to the Editor: Can sarcopenia predict complete response after Total Neoadjuvant Therapy in advanced rectal cancer? A multicentre observational cohort study.
    J Surg Oncol. 2023;128:181-182.
    >> Share

  63. YANG XY, Hu Q
    Can sarcopenia predict complete response after total neoadjuvant therapy in advanced rectal cancer?
    J Surg Oncol. 2023;128:179-180.
    >> Share

  64. BEDRIKOVETSKI S, Traeger L, Price TJ, Carruthers S, et al
    Can sarcopenia predict complete response after total neoadjuvant therapy in advanced rectal cancer? A multicentre observational cohort study.
    J Surg Oncol. 2023;128:75-84.
    >> Share

  65. ROUHI AD, Muhammad HA, Lee B, Eng OS, et al
    Improving online resources for cytoreductive surgery and HIPEC by engaging patients.
    J Surg Oncol. 2023;128:175-176.
    >> Share

  66. EFETOV SK, Zubayraeva AA, Panova PD, Cao Y, et al
    Transrectal specimen extraction (NOSES II) for the laparoscopic distal sigmoid colon resection with mesocolic complete lymph node dissection (video correspondence).
    J Surg Oncol. 2023;128:85-86.
    >> Share

  67. WAGSTAFF JFR, Flood MP, Mohan H, McBain RD, et al
    Perioperative outcomes of cytoreductive surgery for tumours of colorectal or appendiceal origin with ovarian involvement.
    J Surg Oncol. 2023;128:66-74.
    >> Share

    June 2023
  68. LEE JM, Han YD, Cho MS, Hur H, et al
    Neoadjuvant chemotherapy versus upfront surgery as the initial treatment for patients with resectable, synchronous colorectal cancer liver metastases.
    J Surg Oncol. 2023 Jun 8. doi: 10.1002/jso.27308.
    >> Share

  69. MUNIR MM, Woldesenbet S, Alaimo L, Moazzam Z, et al
    Mediators of county-level racial and economic privilege in cancer screening.
    J Surg Oncol. 2023;127:1212-1222.
    >> Share

  70. HE Q, Huang J, Niu L, Zhai C, et al
    A comparison of the efficacy and safety of natural orifice specimen extraction and conventional laparoscopic surgery in patients with sigmoid colon/high rectal cancer.
    J Surg Oncol. 2023;127:1160-1166.
    >> Share

  71. HERNANDEZ MC, Wong P, Melstrom K
    Low anterior resection syndrome.
    J Surg Oncol. 2023;127:1271-1276.
    >> Share

  72. LEIPHRAKPAM PD, Rajappa SJ, Krishnan M, Batra R, et al
    Colorectal cancer: Review of signaling pathways and associated therapeutic strategies.
    J Surg Oncol. 2023;127:1277-1295.
    >> Share

  73. KIM BJ, Hanna MH
    Colorectal cancer in young adults.
    J Surg Oncol. 2023;127:1247-1251.
    >> Share

  74. WILLIAMS JR, Ayscue JM
    Colorectal cancer screening: A review of current screening options, timing, and guidelines.
    J Surg Oncol. 2023;127:1236-1246.
    >> Share

  75. KHALIL M, Abbass MA
    Neoadjuvant immunotherapy in microsatellite unstable colorectal cancer: Are we in the era of nonoperative management?
    J Surg Oncol. 2023;127:1296-1299.
    >> Share

  76. RAMIREZ R, Donohue K
    Current monitoring and treatment for anal intraepithelial neoplasms.
    J Surg Oncol. 2023;127:1306-1309.
    >> Share

  77. CHANG G, Halabi WJ, Ali F
    Management of lateral pelvic lymph nodes in rectal cancer.
    J Surg Oncol. 2023;127:1264-1270.
    >> Share

  78. ABBASS MA, Church J
    Contemporary surgical management of colorectal cancer in Lynch syndrome.
    J Surg Oncol. 2023;127:1259-1263.
    >> Share

  79. BOBEL MC, McGee MF
    Determining the optimal radiation-surgery interval (RSI) for oncologic proctectomy following radiotherapy for rectal adenocarcinoma.
    J Surg Oncol. 2023;127:1252-1258.
    >> Share

    May 2023
  80. JADE F, Marc P, Gabriel L, Clarisse E, et al
    A prediction model to refine the timing of an early second-look laparoscopic exploration in patients with colon cancer at high risk of early peritoneal metastasis recurrence.
    J Surg Oncol. 2023 May 25. doi: 10.1002/jso.27359.
    >> Share

  81. GOFFREDO P, Aguirre N, Mohamed M, Kleiman DA, et al
    Incomplete cytoreductive surgery for appendiceal and colorectal peritoneal carcinomatosis: Characteristics and outcomes of an overlooked group.
    J Surg Oncol. 2023;127:1028-1034.
    >> Share

  82. LEHTONEN TM, Ilvesmaki A, Koskenvuo LE, Lepisto AH, et al
    The ability of magnetic resonance imaging to predict lymph node metastases and the risk of recurrence in rectal cancer.
    J Surg Oncol. 2023;127:991-998.
    >> Share

  83. KATO PJ, Kanters AE, Rivard SJ, Hendren S, et al
    Comparison of surgeon and pathologist total mesorectal excision grade after rectal cancer resection: A single institution analysis.
    J Surg Oncol. 2023;127:983-990.
    >> Share

    April 2023
  84. MOGOLLON-GONZALEZ M, Conde-Muino R, Rodriguez-Fernandez A, Navarro-Pelayo M, et al
    Impact of routine preoperative (18) FDG PET/CT on the surgical management of primary colorectal cancer.
    J Surg Oncol. 2023 Apr 24. doi: 10.1002/jso.27291.
    >> Share

  85. MORGAN RB, Dhiman A, Sood D, Ong CT, et al
    Mutational profiles and prognostic impact in colorectal and high-grade appendiceal adenocarcinoma with peritoneal metastases.
    J Surg Oncol. 2023;127:831-840.
    >> Share

  86. FLEMING AM, Deschner BW, Williard FW, Drake JA, et al
    Peritoneal metastases from primary appendiceal and colorectal carcinomas demonstrate distinct molecular identities on comprehensive tumor analysis.
    J Surg Oncol. 2023;127:815-822.
    >> Share

  87. VAN KOOTEN RT, Ravensbergen CJ, van Buseck SCD, Grootjans W, et al
    Computed tomography-based preoperative muscle measurements as prognostic factors for anastomotic leakage following oncological sigmoid and rectal resections.
    J Surg Oncol. 2023;127:823-830.
    >> Share

  88. HANSDOTTER P, Scherman P, Nikberg M, Petersen SH, et al
    Treatment and survival of patients with metachronous colorectal lung metastases.
    J Surg Oncol. 2023;127:806-814.
    >> Share

  89. KERAMATI MR, Meshkati Yazd SM, Shahriarirad R, Ahmadi Tafti SM, et al
    Hand-sewn direct repair versus resection and hand-sewn anastomosis techniques for the reversal of diverting loop ileostomy after lower anterior rectal resection surgery: A randomized clinical trial.
    J Surg Oncol. 2023;127:798-805.
    >> Share

    March 2023
  90. MANKARIOUS MM, Portolese AC, Hoskins MA, Deutsch MJ, et al
    Neoadjuvant chemotherapy does not increase risk for anastomotic leak for simultaneous resection of primary colon cancer with synchronous liver metastasis: A NSQIP-colectomy analysis.
    J Surg Oncol. 2023 Mar 20. doi: 10.1002/jso.27242.
    >> Share

  91. CUK P, Simonsen RM, Sherzai S, Buchbjerg T, et al
    Surgical efficacy and learning curves of laparoscopic complete mesocolic excision with intracorporeal anastomosis for right-sided colon cancer: A retrospective two-center cohort study.
    J Surg Oncol. 2023 Mar 18. doi: 10.1002/jso.27230.
    >> Share

  92. SHAIKH CF, Woldesenbet S, Munir MM, Moazzam Z, et al
    Association between the environmental quality index and textbook outcomes among Medicare beneficiaries undergoing surgery for colorectal cancer (CRC).
    J Surg Oncol. 2023 Mar 11. doi: 10.1002/jso.27229.
    >> Share

  93. TREASURE T, Macbeth F
    Finding that outcomes after imaging-guided thermal ablation and surgery for colorectal lung metastases are similar does not prove a survival benefit from either.
    J Surg Oncol. 2023;127:510-512.
    >> Share

  94. HANNA DN, Macfie R, Ghani MO, Hermina A, et al
    A total neoadjuvant chemotherapy approach is associated with improved recurrence-free survival in patients with colorectal peritoneal metastases undergoing cytoreductive surgery and HIPEC.
    J Surg Oncol. 2023;127:442-449.
    >> Share

  95. EDWARDS MURPHY A, Earley H, Creavin B, McCullough P, et al
    A palliative stent for an acute large bowel obstruction-A video vignette.
    J Surg Oncol. 2023;127:441.
    >> Share

  96. SEUX H, Gignoux B, Blanchet MC, Frering V, et al
    Ambulatory colectomy for cancer: Results from a prospective bicentric study of 177 patients.
    J Surg Oncol. 2023;127:434-440.
    >> Share

  97. MANGIERI CW, Valenzuela CD, Solsky IB, Erali RA, et al
    Impact of myometrium invasion on survival outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC).
    J Surg Oncol. 2023;127:450-456.
    >> Share

  98. NEARY C, O'Brien L, McCormack E, Kelly M, et al
    Defining a textbook outcome for the resection of colorectal liver metastases.
    J Surg Oncol. 2023;127:616-624.
    >> Share

  99. PARK SY, Park JS, Kim HJ, Kim JG, et al
    Oncological impact of intraperitoneal chemotherapy after cytoreductive surgery for patients with colorectal peritoneal metastasis: A bi-institutional retrospective analysis.
    J Surg Oncol. 2023;127:668-677.
    >> Share

    February 2023
  100. ALAIMO L, Moazzam Z, Woldesenbet S, Lima HA, et al
    Artificial intelligence to investigate predictors and prognostic impact of time to surgery in colon cancer.
    J Surg Oncol. 2023 Feb 25. doi: 10.1002/jso.27224.
    >> Share

  101. KHAN H, Radomski SN, Siddiqi A, Zhou N, et al
    Tumor deposits are associated with a higher risk of peritoneal disease in non-metastatic colorectal cancer patients.
    J Surg Oncol. 2023 Feb 15. doi: 10.1002/jso.27207.
    >> Share

    January 2023
  102. KHAMZINA S, Lee J, Ryoo SB, Kim MJ, et al
    Standard versus longer interval of radical resection after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A 20-year single-center experience & propensity-score matching.
    J Surg Oncol. 2023;127:119-131.
    >> Share

    December 2022
  103. AIKEN T, Hu CY, Uppal A, Francescatti AB, et al
    Peritoneal recurrence after resection for Stage I-III colorectal cancer: A population analysis.
    J Surg Oncol. 2022 Dec 15. doi: 10.1002/jso.27175.
    >> Share

  104. VALENZUELA CD, Moaven O, Gawdi R, Stauffer JA, et al
    Outcomes after repeat hepatectomy for colorectal liver metastases from the colorectal liver operative metastasis international collaborative (COLOMIC).
    J Surg Oncol. 2022;126:1242-1252.
    >> Share

  105. KIMURA J, Sui K, Murokawa T, Tabuchi M, et al
    Reconsideration of indications for third hepatectomy for colorectal liver metastases.
    J Surg Oncol. 2022;126:1232-1241.
    >> Share

  106. NAFFOUJE SA, Manguso N, Imanirad I, Sahin IH, et al
    Neoadjuvant rectal score is prognostic for survival: A population-based propensity-matched analysis.
    J Surg Oncol. 2022;126:1219-1231.
    >> Share

  107. LEE KC, Zhao B, Pianka K, Liu S, et al
    Current trends in nonoperative management for rectal adenocarcinoma: An unequal playing field?
    J Surg Oncol. 2022;126:1504-1511.
    >> Share

  108. FENG Q, Tang W, Zhang Z, Wei Y, et al
    Robotic versus laparoscopic abdominoperineal resections for low rectal cancer: A single-center randomized controlled trial.
    J Surg Oncol. 2022;126:1481-1493.
    >> Share

    November 2022
  109. MALHOTRA G, Lafaro K, Konstantinidis I, Melstrom L, et al
    Tumor extent impacts survival benefit in minimally invasive colectomy for T4 colon cancer: A propensity matched national cohort analysis.
    J Surg Oncol. 2022 Nov 28. doi: 10.1002/jso.27162.
    >> Share

  110. KARAM E, Tabutin M, Dupre A
    Neither surveillance nor treatment showed significant survival benefit for lung metastases from colorectal cancer, imaging guided thermal ablation is a safe and efficient alternative to surgery.
    J Surg Oncol. 2022 Nov 17. doi: 10.1002/jso.27148.
    >> Share

  111. AYLWARD C, Noori J, Tyrrell J, O'sullivan N, et al
    Survival outcomes after synchronous para-aortic lymph node metastasis in colorectal cancer: A systematic review.
    J Surg Oncol. 2022 Nov 9. doi: 10.1002/jso.27139.
    >> Share

    October 2022
  112. RUBINSTEIN JC, Foroughi Pour A, Zhou J, Sheridan TB, et al
    Deep learning image analysis quantifies tumor heterogeneity and identifies microsatellite instability in colon cancer.
    J Surg Oncol. 2022 Oct 17. doi: 10.1002/jso.27118.
    >> Share

  113. PATY PB, Garcia-Aguilar J
    Colorectal cancer.
    J Surg Oncol. 2022;126:881-887.
    >> Share

    September 2022
  114. KARAM E, Tabutin M, Mastier C, Crignis L, et al
    Curative-intent treatment of pulmonary metastases from colorectal cancer: A comparison between imaging-guided thermal ablation and surgery.
    J Surg Oncol. 2022 Sep 28. doi: 10.1002/jso.27108.
    >> Share

  115. ULANJA MB, Ntafam C, Beutler BD, Antwi-Amoabeng D, et al
    Race, age, and sex differences on the influence of obesity on colorectal cancer sidedness and mortality: A national cross-sectional study.
    J Surg Oncol. 2022 Sep 16. doi: 10.1002/jso.27096.
    >> Share

  116. WAGMAN LD, Geller DA, Jacobs SA, Petrelli NJ, et al
    NSABP FC-6: Surgical conversion rate in colorectal cancer patients with unresectable, KRAS wild-type liver metastases receiving mFOLFOX7 plus cetuximab.
    J Surg Oncol. 2022 Sep 16. doi: 10.1002/jso.27078.
    >> Share

  117. WALKER BS, Billingsley KG, Sutton TL, Kolbeck KJ, et al
    Hepatic arterial infusion pump chemotherapy combined with systemic therapy for patients with advanced colorectal liver metastases: Outcomes in a newly established program.
    J Surg Oncol. 2022;126:513-522.
    >> Share

  118. EMILE SH, Madbouly KM, Elfeki H, Shalaby M, et al
    Multicenter validation of the PREDICT score for prediction of local recurrence after total mesorectal excision of rectal cancer.
    J Surg Oncol. 2022;126:772-780.
    >> Share

  119. SOBRADO LF, Nahas CSR, Marques CFS, Sobrado CW, et al
    Pretreatment colostomy in patients with anal squamous cell carcinoma: Risk factors for a permanent stoma.
    J Surg Oncol. 2022;126:740-747.
    >> Share

  120. HAYES IP, Milanzi E, Pelly RM, Gibbs P, et al
    T-stage downstaging of locally advanced rectal cancer after neoadjuvant chemoradiotherapy is not associated with reduced recurrence after adjusting for tumour characteristics.
    J Surg Oncol. 2022;126:728-739.
    >> Share

    August 2022
  121. SHARON CE, Song Y, Straker RJ 3rd, Kelly N, et al
    Impact of the affordable care act's medicaid expansion on presentation stage and perioperative outcomes of colorectal cancer.
    J Surg Oncol. 2022 Aug 19. doi: 10.1002/jso.27070.
    >> Share

  122. GAWDI R, Valenzuela CD, Moaven O, Stauffer JA, et al
    Perioperative chemotherapy for resectable colorectal liver metastases: Analysis from the Colorectal Operative Liver Metastases International Collaborative (COLOMIC).
    J Surg Oncol. 2022;126:339-347.
    >> Share

  123. GUGUSHEFF J, White K, Fitzadam S, Creighton N, et al
    Population-level utilisation of neoadjuvant radiotherapy for the treatment of rectal cancer.
    J Surg Oncol. 2022;126:322-329.
    >> Share

    July 2022
  124. MO TW, Zhang ZJ, Chen YL, Huang JH, et al
    Reply to Comment on "Risk factors for metachronous peritoneal carcinomatosis after radical resection for patients with nonmetastatic pT3-4 colon cancer".
    J Surg Oncol. 2022 Jul 29. doi: 10.1002/jso.27037.
    >> Share

  125. ZOU M, Xu M, Wu WQ, Gao F, et al
    Comment on "Risk factors for metachronous peritonealcarcinomatosis after radical resection for patients with nonmetastatic pT3-4 colon cancer".
    J Surg Oncol. 2022 Jul 29. doi: 10.1002/jso.27001.
    >> Share

  126. DUMONT F, Loaec C, Wernert R, Maurel B, et al
    Surgery of resectable local recurrence following colorectal cancer: Compartmental surgery improves local control.
    J Surg Oncol. 2022 Jul 2. doi: 10.1002/jso.26990.
    >> Share

  127. VAZ DA SILVA DG, Bredt LC, Diniz AL, Vieira VHR, et al
    Brazilian Society of Surgical Oncology surgical standards for resectable colorectal cancer liver metastases.
    J Surg Oncol. 2022;126:28-36.
    >> Share

  128. GUMIERO JL, Oliveira BMS, Neto PAO, Pandini RV, et al
    Timing of resection of synchronous colorectal liver metastasis: A systematic review and meta-analysis.
    J Surg Oncol. 2022;126:175-188.
    >> Share

    June 2022
  129. GRANT RRC, Khan TM, Gregory SN, Coakley BA, et al
    Adjuvant chemotherapy is associated with improved overall survival in select patients with Stage II colon cancer: A National Cancer Database analysis.
    J Surg Oncol. 2022 Jun 14. doi: 10.1002/jso.26970.
    >> Share

  130. JIN L, Hu Q, Sun Y
    Association between enrollment in an enhanced recovery program for colorectal cancer surgery and long-term recurrence and survival.
    J Surg Oncol. 2022 Jun 7. doi: 10.1002/jso.26886.
    >> Share

  131. MO TW, Zhang ZJ, Chen YL, Huang JH, et al
    Risk factors for metachronous peritoneal carcinomatosis after radical resection for patients with nonmetastatic pT3-4 colon cancer.
    J Surg Oncol. 2022 Jun 4. doi: 10.1002/jso.26975.
    >> Share

  132. HU Q, Zhu KF, Sun J
    Preoperative c-reactive protein to prealbumin ratio is independently associated with prognosis in patients with resectable colorectal cancer.
    J Surg Oncol. 2022 Jun 2. doi: 10.1002/jso.26927.
    >> Share

  133. WU J, Huang Z
    Reply to the comments on "Preoperative C-reactive protein to prealbumin ratio is independently associated with prognosis in patients with resectable colorectal cancer".
    J Surg Oncol. 2022 Jun 2. doi: 10.1002/jso.26968.
    >> Share

  134. SUGARBAKER PH, Ghabra S
    Protocols versus practice in the management of colorectal peritoneal metastases.
    J Surg Oncol. 2022;125:1200-1201.
    >> Share

  135. SUTTON TL, Wong LH, Walker BS, Dewey EN, et al
    Surgical timing after preoperative chemotherapy is associated with oncologic outcomes in resectable colorectal liver metastases.
    J Surg Oncol. 2022;125:1260-1268.
    >> Share

    May 2022
  136. CUIJPERS ACM, Lubbers T, van Rens HA, Smit-Fun V, et al
    The patient perspective on the preoperative colorectal cancer care pathway and preparedness for surgery and postoperative recovery-a qualitative interview study.
    J Surg Oncol. 2022 May 17. doi: 10.1002/jso.26920.
    >> Share

  137. YAN XL, Wang K, Bao Q, Wang HW, et al
    Prognostic value of the combination of primary tumor location and RAS mutational status on patients with colorectal liver metastasis undergoing hepatectomy.
    J Surg Oncol. 2022;125:1002-1012.
    >> Share

  138. MASSUCCO P, Fontana AP, Balbo Mussetto A, Desana B, et al
    MRI-detected extramural vascular invasion (mrEMVI) as the best predictive factor to identify candidates to total neoadjuvant therapy in locally advanced rectal cancer.
    J Surg Oncol. 2022;125:1024-1031.
    >> Share

  139. HAN J, Wang X, Zhang C, Wu Q, et al
    Clinicopathological and prognostic significance of HER2 status in surgically resected colorectal liver metastases.
    J Surg Oncol. 2022;125:991-1001.
    >> Share

    April 2022
  140. HAYES IP, Milanzi E, Gibbs P, Faragher I, et al
    Is increasing nodal count associated with improved recurrence-free and overall survival following standard right hemicolectomy for colon cancer?
    J Surg Oncol. 2022 Apr 28. doi: 10.1002/jso.26913.
    >> Share

  141. JULIO C, Benoist S, Allard MA, Navarro F, et al
    Treatment strategies to resectable metachronous colorectal liver metastases after adjuvant oxaliplatin-based chemotherapy for primary colorectal cancer.
    J Surg Oncol. 2022 Apr 9. doi: 10.1002/jso.26885.
    >> Share

  142. SUGARBAKER PH, Chang D
    Revised prognostic indicators for treatment of lymph node positive colorectal peritoneal metastases.
    J Surg Oncol. 2022;125:889-900.
    >> Share

  143. MADBOULY KM, Emile SH, Gamal AA
    Transanal total mesorectal excision (TaTME) with delayed coloanal anastomosis versus TaTME with immediate coloanal anastomosis and temporary diversion in middle and low rectal cancer.
    J Surg Oncol. 2022;125:865-871.
    >> Share

    March 2022
  144. CHEN P, Hu Q, Sun Y
    Aerobic fitness and muscle density play a vital role in postoperative complications in colorectal cancer surgery.
    J Surg Oncol. 2022 Mar 30. doi: 10.1002/jso.26849.
    >> Share

  145. HU Q, Sun Y, Yang X
    Evaluating the longitudinal effect of colorectal surgery on health-related quality of life in patients with colorectal cancer.
    J Surg Oncol. 2022 Mar 30. doi: 10.1002/jso.26837.
    >> Share

  146. HU Q, Sun YS, Yang XY
    What are the factors predictive of postoperative complications in patients with colorectal cancer undergoing stenting as a bridge to surgery?
    J Surg Oncol. 2022 Mar 30. doi: 10.1002/jso.26824.
    >> Share

  147. CUIJPERS ACM, Bongers BC, Stassen PS, Lubbers T, et al
    Reply letter to the editor: Aerobic fitness and muscle density play a vital role in postoperative complications in colorectal cancer surgery.
    J Surg Oncol. 2022 Mar 29. doi: 10.1002/jso.26878.
    >> Share

  148. ZORRILLA-VACA A, Ripolles-Melchor J, Abad-Motos A, Mingu IR, et al
    Association between enrollment in an enhanced recovery program for colorectal cancer surgery and long-term recurrence and survival.
    J Surg Oncol. 2022 Mar 2. doi: 10.1002/jso.26836.
    >> Share

  149. MEI F, Yang X, Na L, Yang L, et al
    Anal preservation on the psychology and quality of life of low rectal cancer.
    J Surg Oncol. 2022;125:484-492.
    >> Share

  150. HREBINKO KA, Reitz KM, Mohammed MK, Nassour I, et al
    Transanal excision with adjuvant therapy for pT1N0 rectal tumors with high-risk features offers equivalent survival to radical resection: A National Cancer Database analysis.
    J Surg Oncol. 2022;125:475-483.
    >> Share

  151. SHANNON AB, Straker RJ, Keele L, Kelz RR, et al
    The impact of hospital volume on racial disparities in resected rectal cancer.
    J Surg Oncol. 2022;125:465-474.
    >> Share

  152. HE S, Liu Z, Li L, Zhang J, et al
    Improvement of low anterior resection syndrome beyond 2 years after total mesorectal excision.
    J Surg Oncol. 2022;125:448-456.
    >> Share

  153. JAGANMURUGAN R, Kazi M, Sukumar V, Gori J, et al
    Bladder preserving robotic pelvic exenteration for locally advanced rectal cancer-technique and short-term outcomes.
    J Surg Oncol. 2022;125:493-497.
    >> Share

  154. FERRAL H, Alonzo MJ, Datri J, Hogg ME, et al
    Endovascular management of portal vein obstruction in hepatobiliary cancer patients.
    J Surg Oncol. 2022;125:392-398.
    >> Share

  155. NI K, Zhan Y, Liu Z, Zhao XZ, et al
    Mismatch repair system deficiency is associated with chemoradiotherapy resistance in locally advanced rectal adenocarcinoma patients.
    J Surg Oncol. 2022;125:692-702.
    >> Share

  156. MANGIERI CW, Moaven O, Valenzuela CD, Erali RA, et al
    Utility of hyperthermic intraperitoneal chemotherapy in cases of incomplete cytoreductive surgery.
    J Surg Oncol. 2022;125:703-711.
    >> Share

  157. KOLBEINSSON HM, Hoppe A, Walker J, Chandana S, et al
    Recurrence and survival after curative-intent treatment for colorectal liver metastases: Implications for adjuvant liver-directed regional chemotherapy.
    J Surg Oncol. 2022;125:664-670.
    >> Share

    February 2022
  158. SUN Y, Yu D, Zhong J, Lin Y, et al
    Para-aortic lymph node dissection in left-sided colorectal cancer: Risk factors, prognostic impact, and therapeutic value.
    J Surg Oncol. 2022 Feb 24. doi: 10.1002/jso.26829.
    >> Share

  159. HUANG Z, Cai P, Zhao Y, Niu D, et al
    Preoperative C-reactive protein to prealbumin ratio is independently associated with prognosis in patients with resectable colorectal cancer.
    J Surg Oncol. 2022 Feb 17. doi: 10.1002/jso.26823.
    >> Share

  160. CUIJPERS ACM, Bongers BC, Heldens AFJM, Bours MJL, et al
    Aerobic fitness and muscle density play a vital role in postoperative complications in colorectal cancer surgery.
    J Surg Oncol. 2022 Feb 11. doi: 10.1002/jso.26817.
    >> Share

  161. VALADAO M, Cesar D, Veo CAR, Araujo RO, et al
    Brazilian society of surgical oncology: Guidelines for the surgical treatment of mid-low rectal cancer.
    J Surg Oncol. 2022;125:194-216.
    >> Share

    January 2022
  162. ADACHI Y, Tokunaga R, Matsumoto K, Nakao Y, et al
    What are the factors predictive of postoperative complications in patients with colorectal cancer undergoing stenting as a bridge to surgery?
    J Surg Oncol. 2022 Jan 31. doi: 10.1002/jso.26803.
    >> Share

  163. NARAYAN RR, Aveson VG, Chou JF, Walch HS, et al
    Association of genomic profiles and survival in early onset and screening-age colorectal cancer patients with liver metastases resected over 15 years.
    J Surg Oncol. 2022 Jan 23. doi: 10.1002/jso.26797.
    >> Share

  164. PARK LJ, Daza JF, Li V, Workneh A, et al
    Prognostic factors of overall survival in patients with recurrent disease following liver resection for colorectal cancer metastases: A multicenter external validation study.
    J Surg Oncol. 2022 Jan 20. doi: 10.1002/jso.26796.
    >> Share

  165. FOSTER JM, Alexander HR, Zhang C
    Regional therapy trials in peritoneal metastases: The path to standardization-Colorectal cancer.
    J Surg Oncol. 2022;125:57-63.
    >> Share

  166. WHELAN S, Burneikis D, Kalady MF
    Rectal cancer: Maximizing local control and minimizing toxicity.
    J Surg Oncol. 2022;125:46-54.
    >> Share

    December 2021
  167. CHODOFF A, Smith KC, Shukla A, Blackford AL, et al
    Colorectal cancer survivorship care plans: Variations in documentation and posttreatment surveillance recommendations.
    J Surg Oncol. 2021 Dec 11. doi: 10.1002/jso.26767.
    >> Share

  168. SERRANO PE, Parpia S, Karanicolas P, Gallinger S, et al
    Simultaneous resection for synchronous colorectal cancer liver metastases: A feasibility clinical trial.
    J Surg Oncol. 2021 Dec 8. doi: 10.1002/jso.26764.
    >> Share

  169. KIM JC, Ha YJ, Park IJ, Kim CW, et al
    Tumor immune microenvironment of primary colorectal adenocarcinomas metastasizing to the liver or lungs.
    J Surg Oncol. 2021;124:1136-1145.
    >> Share

  170. YANG W, Liu Q, Lin G, Zhang B, et al
    The effect of neoadjuvant imatinib therapy on outcome and survival in rectal gastrointestinal stromal tumors: A multiinstitutional study.
    J Surg Oncol. 2021;124:1128-1135.
    >> Share

  171. YOON DH, Ibrahim A, Tatishchev S, Duldulao MPN, et al
    Prevalence of mesothelin expression in peritoneal disease from colorectal and appendiceal cancers.
    J Surg Oncol. 2021;124:1091-1097.
    >> Share

  172. WANG Y, Zhang Y, Lin H, Xu M, et al
    Risk factors for lymph node metastasis in rectal neuroendocrine tumors: A recursive partitioning analysis based on multicenter data.
    J Surg Oncol. 2021;124:1098-1105.
    >> Share

  173. LI Z, Wang Y, Ying X, Zhang L, et al
    Prognostic and predictive value of mismatch repair deficiency in gastric and gastroesophageal junction adenocarcinoma patients receiving neoadjuvant or adjuvant chemotherapy.
    J Surg Oncol. 2021;124:1356-1364.
    >> Share

  174. MENG W, Yang B, Huang B, Chen C, et al
    Impact of preoperative transcatheter rectal arterial chemoembolization with concurrent chemoradiotherapy on surgery and prognosis of patients with locally advanced rectal cancer.
    J Surg Oncol. 2021;124:1451-1458.
    >> Share

  175. DAMASCENO AM, Kesley R, Paolino BS, Dos Santos do Amaral MR, et al
    Perioperative score for octogenarian patients eligible for rectal cancer surgery.
    J Surg Oncol. 2021;124:1409-1416.
    >> Share

  176. KAZI M, Jain D, Padhy AS, Menon M, et al
    Optimal neoadjuvant strategy for signet ring cell carcinoma of the rectum-Is TNT the solution?
    J Surg Oncol. 2021;124:1417-1430.
    >> Share

    November 2021
  177. BRAJCICH BC, Benson AB, Gantt G, Eng OS, et al
    Management of colorectal cancer during the COVID-19 pandemic: Recommendations from a statewide multidisciplinary cancer collaborative.
    J Surg Oncol. 2021 Nov 25. doi: 10.1002/jso.26758.
    >> Share

  178. HU Q, Sun YS, Yang XY
    Comment on "Comparison of open and minimally invasive approaches to colon cancer resection in compliance with 12 regional lymph node harvest quality measure".
    J Surg Oncol. 2021 Nov 17. doi: 10.1002/jso.26580.
    >> Share

    October 2021
  179. NUMATA M, Shiozawa M, Godai T, Kazama K, et al
    Prediction of lateral lymph node metastasis using OSNA method for mesorectal lymph nodes in low rectal cancer: A prospective study by the Kanagawa Yokohama Colorectal Cancer Study Group (KYCC1801).
    J Surg Oncol. 2021 Oct 27. doi: 10.1002/jso.26730.
    >> Share

    September 2021
  180. REUDINK M, Molenaar CJL, Bonhof CS, Janssen L, et al
    Evaluating the longitudinal effect of colorectal surgery on health-related quality of life in patients with colorectal cancer.
    J Surg Oncol. 2021 Sep 27. doi: 10.1002/jso.26685.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016